isopentyl phenyl ether | 1129-64-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: isopentyl phenyl ether
• 英文别名: iso-Pentyloxybenzene；3-methylbutyl phenyl ether；(isopentyloxy)benzene；isoamyl phenyl ether；phenyl isoamyl ether；isopentyl-phenyl ether；Ether, isopentyl phenyl；3-methylbutoxybenzene
• CAS: 1129-64-2
• 化学式: C₁₁H₁₆O
• mdl: MFCD00048367
• 分子量: 164.247
• InChiKey: ZSBTVXBAENDZBH-UHFFFAOYSA-N

物化性质

• 沸点：
  221-225 °C
• 密度：
  0.913±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.454
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2909309090

反应信息

• 作为反应物：
  描述：

  isopentyl phenyl ether 在 硫酸 作用下， 生成 异戊酸
  参考文献：
  名称：

  Fichter; Dietrich, Helvetica Chimica Acta, 1924, vol. 7, p. 135

  摘要：

  DOI：
• 作为产物：
  描述：

  异戊醇 在 氯化亚砜 、 甲苯 作用下， 生成 isopentyl phenyl ether
  参考文献：
  名称：

  Voss; Blanke, Justus Liebigs Annalen der Chemie, 1931, vol. 485, p. 258,279

  摘要：

  DOI：

文献信息

• Pyridine- and Pyrimidinecarboxamides as CXCR2 Modulators
  申请人：Maeda Dean Y.

  公开号：US20100210593A1

  公开（公告）日：2010-08-19

  There is disclosed pyridine- and pyrimidinecarboxamide compounds useful as pharmaceutical agents, synthesis processes, and pharmaceutical compositions which include pyridine- and pyrimidinecarboxamides compounds. More specifically, there is disclosed a genus of CXCR2 inhibitor compounds that are useful for treating a variety of inflammatory and neoplastic disorders.

  披露了作为药物剂的吡啶和嘧啶羧酰胺化合物，合成过程以及包括吡啶和嘧啶羧酰胺化合物的药物组合物。更具体地，披露了一类CXCR2抑制剂化合物，可用于治疗各种炎症和肿瘤性疾病。
• Prevalence of Rheumatic Fever and Rheumatic Heart Disease in Yemen
  作者：Abdul Nasser Al-Munibari、Thabet Mohsen Nasher、Siddig Ahmed Ismail、El-Daw Ahmed Mukhtar

  DOI：10.1177/021849230100900111

  日期：2001.3

  The major aim of this study was to determine the prevalence of rheumatic heart disease in Yemen. Between October 1997 and March 1998, a prospective cluster-sampling screening study was carried out on 5000 schoolchildren (2504 female and 2496 male), aged 5 to 18 years. Suspected cases were subjected to electrocardiography, chest radiography, and Doppler echocardiography. Although no case of active rheumatic fever was found, 12 girls and 6 boys were affected by the disease, giving a prevalence of 3.6 per 1000, which is higher than that reported from neighboring countries. All confirmed and suspected cases were given penicillin G benzathine every 3 weeks, according to body weight, after a test dose. Prevention programs for rheumatic fever, together with prevention of streptococcal throat infections, are goals for the near future.

  这项研究的主要目的是确定也门风湿性心脏病的患病率。在1997年10月至1998年3月期间，对5000名年龄在5至18岁之间的学童（2504名女性和2496名男性）进行了一项前瞻性集群抽样筛查研究。疑似病例接受了心电图、胸部X光和多普勒超声心动图检查。尽管未发现活动性风湿热病例，但有12名女孩和6名男孩患有该疾病，患病率为每千人3.6例，高于邻国的报道。所有确诊和疑似病例每3周按体重给予苄青霉素G，先进行试验剂量。风湿热的预防计划，以及预防链球菌喉部感染，是未来的目标。
• Recognition through Self-Assembly. A Quadruply-Hydrogen-Bonded, Strapped Porphyrin Cleft That Binds Dipyridyl Molecules and a [2]Rotaxane
  作者：Xue-Bin Shao、Xi-Kui Jiang、Xin Zhao、Cheng-Xue Zhao、Yan Chen、Zhan-Ting Li

  DOI：10.1021/jo0351872

  日期：2004.2.1

  porphyrin. The 2-ureidopyrimidin-4(1H)-one unit dimerizes exclusively in chloroform even at the dilute concentration of 10-4 M, while the two “strapped” zinc porphyrin units of the homodimer provide additional binding sites for selective guest recognition. 1H NMR studies indicate that the new homodimer Zn1·Zn1 adopts an S-type conformation due to strong donor−acceptor interaction between the electron-rich

  四重氢基键合的卟啉二聚体的Zn1 ·的Zn1已被设计，装配，并且评价为它的能力结合吡啶客人在氯仿超分子裂功能受体d。单体Zn1由2-Meiderpyrimidin-4（1 H）-one单元（最初由Meijer等人报道）和锌卟啉单元组成。卟啉锌被另外的脂族链束缚，以控制卟啉的阻转异构化。2- ureidopyrimidin-4（1 ħ） -酮单元的氯仿甚至在10稀释浓度只二聚- 4M，而同型二聚体的两个“带状”锌卟啉单元则为选择性的客体识别提供了额外的结合位点。1 H NMR研究表明，由于富含电子的卟啉单元与缺乏电子的2-ureidopyrimidin-4（1 H）-一个单元之间强的供体-受体相互作用，新的同型二聚体Zn1 · Zn1采用S型构型。1 H NMR，UV-VIS，和蒸气压渗透压测定法调查揭示的Zn1 ·的Zn1可以作为新一代超分子组装裂功能，能够不仅有效地结合线性吡啶分子14 -
• Heterogeneous Palladium-Catalyzed Synthesis of Aromatic Ethers by Solvent-Free Dehydrogenative Aromatization: Mechanism, Scope, and Limitations Under Aerobic and Non-Aerobic Conditions
  作者：Marc Sutter、Romain Lafon、Yann Raoul、Estelle Métay、Marc Lemaire

  DOI：10.1002/ejoc.201300485

  日期：2013.9

  derivatives and alcohols, both non-aromatic precursors, aryl ethers could be synthesized in good yields and with good selectivities in the presence of a catalytic amount of Pd/C, in one step, without added solvent, in a reaction vessel open to air. For less reactive substrates, the addition of 1-octene in a closed system under non-aerobic conditions improved the conversion. In addition, the catalyst could

  以环己酮衍生物和醇为原料，这两种非芳香族前体，芳醚可以在催化量的 Pd/C 存在下以良好的产率和良好的选择性在一个步骤中合成，无需添加溶剂，在打开的反应容器中空气。对于反应性较低的底物，在非有氧条件下在封闭系统中添加 1-辛烯可提高转化率。此外，催化剂可以循环多次使用，芳醚收率没有下降。该方法也用于四氢萘酮衍生物和多元醇。进行了几个反应以提出这种转化的机制。形成烯醇醚，然后进行脱氢反应似乎是该反应的关键步骤。
• SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS
  申请人：Old David W.

  公开号：US20100093729A1

  公开（公告）日：2010-04-15

  A compound comprising or a pharmaceutically acceptable salt, prodrug, or a metabolite thereof is disclosed herein. Y, A, and B are as described herein. Methods, compositions, and medicaments related to these compounds are also disclosed.

  本文揭示了一种包含或其药用可接受的盐、前药或代谢产物的化合物。Y、A和B如本文所述。还公开了与这些化合物相关的方法、组合物和药物。

表征谱图